4//SEC Filing
SLONIN JONATHAN 4
Accession 0001628280-25-053205
CIK 0001396814other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:32 PM ET
Size
5.2 KB
Accession
0001628280-25-053205
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-11-17$24.09/sh−3,960$95,396→ 178,367.009 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001875723
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:32 PM ET
- Size
- 5.2 KB